Colin Ng & Partners LLP (“CNP”) advised Fund Singapore Pte. Ltd.—a financial institution regulated by the Monetary Authority of Singapore (MAS), and Singapore’s premier equity and lending-based crowdfunding company – on the funding of $1,165,000 equity investment for ClearBridge BioMedics, a Singapore Bio-Medical company. The company is targeting an Initial Public Offering (IPO) in the fourth quarter of 2018 and this is part of their $6.6million Pre-IPO fundraising effort.
Mr Christopher Huang (Partner), Mr Randall Perera (Senior Associate) and Mr Rajkumar Mannar (Associate) advised Fund Singapore Pte. Ltd. in this transaction.